Frontage Hldgs Corp.

Frontage Holdings delivers global end‑to‑end drug development—including medicinal chemistry, ADME/DMPK, safety, early‑phase trials, and API synthesis—to pharma, biotech, & agro firms across 7 continents.

Headquarters: Hong Kong S.A.R. (HKG)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Research Services

Employees: 1,540
HQ: Exton

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
1521	Frontage Hldgs Corp. Cap: 2.0B \| P/E: 99.0	EQUITY	HKG	HKD	KYG3679P1019	Active	📈